Find the Gaps Before the Regulators Do
In January 2026, the FDA issued its first Form 483
inspection finding against a physician-owned med spa
in Texas. At the same time, New York conducted a statewide sweep of 230+ MedSpa's, citing 87 for drug handling violations.
Outcomes ranged from fines to permanent license revocations.
In 3 minutes you'll know whether your drug sourcing meets federal and state requirements and if your documentation would survive a surprise inspection or records request.
You'll also see exactly where your IV therapy, peptide, or compounding practice is most exposed and what your single biggest compliance gap is right now.
Copyright © 2026 claritasaxis.com - All Rights Reserved.